Aptevo Therapeutics: Q4 Earnings Insights
Aptevo Therapeutics (NASDAQ:APVO) reported its Q4 earnings results on Thursday, March 24, 2022 at 08:00 AM.
Here's what investors need to know about the announcement.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's session, 454 stocks hit new 52-week lows.
60 Biggest Movers From Yesterday
Gainers
US Ecology, Inc. (NASDAQ: ECOL) shares surged 67.7% to close at $47.25 on Wednesday after Republic Services reported it will buy the company at $48 per share in cash.
Why Are Aptevo Therapeutics Shares Trading Higher Today?
Aptevo Therapeutics Inc (NASDAQ: APVO)
40 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
US Ecology, Inc. (NASDAQ: ECOL) shares jumped 68.1% to $47.34 after Republic Services reported it will buy the company at $48 per share in cash.
Alligator Bioscience & Aptevo Therapeutics Announce Co-Publication In Peer-Reviewed Journal, ‘Nature Communication’
Alligator Bioscience AB ("Alligator") and Aptevo Therapeutics ("Aptevo") (NASDAQ:APVO) today announced publication of an article in the December 15, 2021, issue of the peer-reviewed
Aptevo Therapeutics On Monday Published 2 Poster Presentations Ahead Of American Society Of Hematology, 1 Poster For Cytokine Release Syndrome, 1 For Single Agent Anti-Neplastic Activity
https://aptevotherapeutics.gcs-web.com/static-files/893a3758-337a-4f06-824a-64da0cebf9dd
https://aptevotherapeutics.gcs-web.com/static-files/638ab153-b1ff-49ee-b4b3-b1bed667bf73
22 Stocks Moving in Monday’s Pre-Market Session
Gainers
Petros Pharmaceuticals, Inc. (NASDAQ: PTPI) rose 32.6% to $3.58 in pre-market trading after gaining more than 14% on Friday.